Full-Time

Director – External Supply Operations

Posted on 10/31/2023

Cytokinetics

Cytokinetics

501-1,000 employees

Develops drugs for muscle function disorders

Biotechnology
Healthcare

Compensation Overview

$194k - $237kAnnually

Senior

San Bruno, CA, USA

Category
Inventory Management
Quality Control & Compliance
Supply Chain Management
Operations & Logistics
Required Skills
Communications
Requirements
  • BS/BA Degree in Life Science, Biology, or Engineering discipline
  • 15+ years combined experience in manufacturing, outsourced operations, technical operations, and/or supply chain in regulated healthcare industry
  • Technical background with knowledge of engineering and pharmaceutical manufacturing processes
  • Ability to function in a fast-paced, high-growth, entrepreneurial environment
  • Ability to travel domestically and internationally ~15%
  • Strong working knowledge and understanding of regulations by government agencies affecting the pharmaceutical industry (CFR's)
  • Timely and effective communication across multiple audiences, both verbally and in writing
Responsibilities
  • Build and maintain relationships with external contract manufacturers and internal global colleagues
  • Ensure timely and effective execution of all supply plans at assigned CMO’s
  • Develop and manage production processes to support operational execution
  • Support logistics, transportation, and import/export activities
  • Lead all aspects of Supply Execution with assigned CMOs
  • Act as supply chain representative for review and approval of documentation
  • Support product qualification activities
  • Develop and execute manufacturing strategies for product launches
  • Collaborate with the Supply Planning team
  • Manage and track inventory
  • Issue purchase orders and track invoices and budgets
  • Maintain production schedules and track batch record execution
  • Support negotiation of price tiers and terms across multiple sources of supply
  • Oversee performance assessment and utilization of KPIs of contract manufacturing partners
  • Oversee revisions to manufacturing cGMP and non GMP documentation
  • Provide input for evaluation of process deviations and assist in the investigation of product complaints
  • Support the design, implementation, and monitoring of supply risk mitigation strategies
  • Build and maintain strong partnerships and provide effective communications with stakeholders
  • Responsible for scheduling and maintaining routine business operations meetings with CMO’s

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a range of drugs in clinical trials, including omecamtiv mecarbil and reldesemtiv, aimed at treating conditions like heart failure, hypertrophic cardiomyopathy, amyotrophic lateral sclerosis, and spinal muscular atrophy. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from debilitating muscle-related conditions.

Company Stage

IPO

Total Funding

$58.4M

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

-1%

1 year growth

-5%

2 year growth

-2%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent investments indicate strong interest in muscle activators and inhibitors.
  • Strategic partnerships, like with Sanofi, expand market reach and potential revenue.
  • Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

What critics are saying

  • Increased competition could impact market share and profitability.
  • Potential delays in clinical trials could hinder drug commercialization.
  • Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
  • The company has a robust pipeline including omecamtiv mecarbil and aficamten.
  • Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE